ClinicalTrials.Veeva

Menu

Association Between Periodontitis and the Level of Anti-citrullinated Protein Antibodies in Rheumatoid Arthritis

M

Misr International University

Status

Completed

Conditions

Periodontal Diseases
Rheumatoid Arthritis

Treatments

Other: Non surgical periodontal treatment

Study type

Observational

Funder types

Other

Identifiers

NCT05706493
PER 3312007

Details and patient eligibility

About

the relationship between rheumatoid arthritis and periodontal disease is crucial and has been explained via a complex interplay of genetic, environmental, and hormonal factors that influence the host immune tolerance leading to both disease characteristics. The aim of this study is to clinically investigate the correlation between the levels of anti-citrullinated protein antibodies (ACPAs) in gingival crevicular fluid before and after non-surgical periodontal treatment and the severity of periodontal disease and rheumatoid arthritis in rheumatoid arthritis (RA) patients

Full description

the relationship between rheumatoid arthritis and periodontal disease is crucial and has been explained via a complex interplay of genetic, environmental, and hormonal factors that influence the host immune tolerance leading to both disease characteristics.

The aim of this study is to clinically investigate the correlation between the levels of anti-citrullinated protein antibodies (ACPAs) in gingival crevicular fluid before and after non-surgical periodontal treatment and the severity of periodontal disease and rheumatoid arthritis in rheumatoid arthritis (RA) patients Materials and Methods: a total of 40 participants suffering from periodontitis and rheumatoid arthritis will be referred from the Badr Hospital (Faculty of Medicine, Helwan University) to Misr international university's dental clinic complex. Gingival crevicular fluid (GCF) samples will be collected from the patients before performing periodontal therapy (baseline). Assessment of ACPAs will be quantified using enzyme-linked immunoassay (ELISA) as the primary outcome at baseline and after 3 months. Assessment of 2ry outcomes includes clinical periodontal and RA parameters at baseline and after 3 months.

Enrollment

36 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Rheumatoid patients fulfilling the ACR criteria for the classification of RA

    • 18 years
  • Both genders

  • Presence of at least 8 teeth

Exclusion criteria

  • Smoking
  • Diabetes Mellitus
  • Pregnant females
  • Patients who had undergone periodontal treatment within last 3 months
  • Antibiotic therapy during last 3 months
  • Other autoimmune diseases

Trial design

36 participants in 1 patient group

Non-surgical periodontal treatment
Description:
assessment of different periodontal parameters and gingival crevicular fluid sampling will be done then non surgical periodontal treatment will be performed then after 3 months re assessment of the periodontal parameters and gingival crevicular fluid sampling will be done

Trial contacts and locations

1

Loading...

Central trial contact

Yahia Hasssan, Lecturer; Zainab Hafez, Lecturer

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems